ERN1 and Sepsis: Moreover, fluvoxamine is rated as a strong σ-1 receptor (S1R) agonist, reducing the damaging aspects of the inflammatory response during sepsis through the S1R-IRE1 pathway and decreasing shock in murine sepsis models [46] similar to lysosomotropic desipramine [23].